These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9467939)

  • 41. Aurora-A amplification associated with BRCA2 mutation in breast tumours.
    Bodvarsdottir SK; Hilmarsdottir H; Birgisdottir V; Steinarsdottir M; Jonasson JG; Eyfjord JE
    Cancer Lett; 2007 Apr; 248(1):96-102. PubMed ID: 16860930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables.
    Johannsdottir HK; Johannesdottir G; Agnarsson BA; Eerola H; Arason A; Johannsson OT; Heikkilä P; Egilsson V; Olsson H; Borg A; Nevanlinna H; Barkardottir RB
    Anticancer Res; 2004; 24(5A):2681-7. PubMed ID: 15521105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
    Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
    Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes.
    Theile M; Hartmann S; Scherthan H; Arnold W; Deppert W; Frege R; Glaab F; Haensch W; Scherneck S
    Oncogene; 1995 Feb; 10(3):439-47. PubMed ID: 7845668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
    Grzybowska E; Zientek H; Jasinska A; Rusin M; Kozlowski P; Sobczak K; Sikorska A; Kwiatkowska E; Gorniak L; Kalinowska E; Utracka-Hutka B; Wloch J; Chmielik E; Krzyzosiak WJ
    Hum Mutat; 2000 Dec; 16(6):482-90. PubMed ID: 11102977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene.
    Varley JM; Thorncroft M; McGown G; Appleby J; Kelsey AM; Tricker KJ; Evans DG; Birch JM
    Oncogene; 1997 Feb; 14(7):865-71. PubMed ID: 9047394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.
    Varley JM; Brammar WJ; Lane DP; Swallow JE; Dolan C; Walker RA
    Oncogene; 1991 Mar; 6(3):413-21. PubMed ID: 2011397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
    Prosser J; Thompson AM; Cranston G; Evans HJ
    Oncogene; 1990 Oct; 5(10):1573-9. PubMed ID: 2250913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Replication error in human breast cancer: comparison with clinical variables and family history of cancer.
    Huiping C; Johannsdottir JT; Arason A; Olafsdottir GH; Eiriksdottir G; Egilsson V; Ingvarsson S
    Oncol Rep; 1999; 6(1):117-22. PubMed ID: 9864413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions.
    Smith PD; Crossland S; Parker G; Osin P; Brooks L; Waller J; Philp E; Crompton MR; Gusterson BA; Allday MJ; Crook T
    Oncogene; 1999 Apr; 18(15):2451-9. PubMed ID: 10229196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
    Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
    Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chromosome arm 17p13.3: could HIC1 be the one ?].
    Chopin V; Leprince D
    Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Brca1 and Brca2 proteins and tumor pathogenesis.
    Ingvarsson S
    Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed müllerian tumours.
    Abeln EC; Smit VT; Wessels JW; de Leeuw WJ; Cornelisse CJ; Fleuren GJ
    J Pathol; 1997 Dec; 183(4):424-31. PubMed ID: 9496259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of heterozygosity studies on chromosome 17 in head and neck cancer using microsatellite markers.
    Adamson R; Jones AS; Field JK
    Oncogene; 1994 Jul; 9(7):2077-82. PubMed ID: 8208554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds.
    Neuhausen SL; Marshall CJ
    Cancer Res; 1994 Dec; 54(23):6069-72. PubMed ID: 7954448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group.
    Eccles DM; Russell SE; Haites NE; Atkinson R; Bell DW; Gruber L; Hickey I; Kelly K; Kitchener H; Leonard R
    Oncogene; 1992 Oct; 7(10):2069-72. PubMed ID: 1408149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma.
    Kirkpatrick H; Waber P; Hoa-Thai T; Barnes R; Osborne-Lawrence S; Truelson J; Nisen P; Bowcock A
    Oncogene; 1997 May; 14(18):2189-93. PubMed ID: 9174054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.
    Kobayashi M; Kawashima A; Mai M; Ooi A
    Am J Pathol; 1996 Nov; 149(5):1575-84. PubMed ID: 8909247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Absence of TP53 alterations in pheochromocytomas and medullary thyroid carcinomas.
    Herfarth KK; Wick MR; Marshall HN; Gartner E; Lum S; Moley JF
    Genes Chromosomes Cancer; 1997 Sep; 20(1):24-9. PubMed ID: 9290950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.